Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Proffered Abstracts - Poster Presentations

Abstract 43: The Colon Cancer Family Registry: A major resource for post-GWAS gene-environment studies.

Aung Ko Win, Daniel D. Buchanan, Noralane M. Lindor, Robert W. Haile, Polly A. Newcomb, Loic Le Marchand, Steven Gallinger, Hopper L. John, Casey Graham and Mark A. Jenkins
Aung Ko Win
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel D. Buchanan
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noralane M. Lindor
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert W. Haile
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polly A. Newcomb
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loic Le Marchand
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Gallinger
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hopper L. John
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casey Graham
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark A. Jenkins
1The University of Melbourne, Parkville, Australia, 2Queensland Institute of Medical Research, Bribane, Australia, 3Mayo Clinic, Phoenix, AZ, 4University of Southern California, Los Angeles, CA, 5Hutchinson Cancer Research Center, Seattle, WA, 6University of Hawaii Cancer Center, Honolulu, HI, 7Mount Sinai Hospital, Toronto, ON, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.GWAS-43 Published November 2012
  • Article
  • Info & Metrics
Loading

Abstract

Background: The Colorectal Cancer Family Registry (Colon CFR) has served as an international resource for studies of the genetics and epidemiology of colorectal cancer (CRC) since 1997. It is the largest family-based resource in the world for the study of CRC and other cancers, such as endometrial cancer, that occur in CRC families. The Colon CFR has recruited participants via six institutions: Cancer Care Ontario, Fred Hutchinson Cancer Research Center, Mayo Clinic, University of Hawaii, University of Southern California Consortium, and University of Melbourne.

Methods: CRC cases were recruited from both population-based cancer registries and family cancer clinics. Controls were recruited from population-based sources. Relatives were recruited via cases and controls. Participants were asked to: donate a blood sample; give permission to access any tumor tissue; complete a detailed personal and family history of cancer including degree of relationship, site of cancer and age of diagnosis; and complete a detailed baseline lifestyle questionnaire that was administered across all recruitment sites, which included items on established and suspected risk factors for colorectal cancer: personal characteristics including age, sex, height and weight, country of birth, ethnicity, race and religion; history of exercise, alcohol consumption and smoking; medication use including NSAIDs, cholesterol-lowering agents, diabetes medication and post- menopausal hormone use; history of colorectal cancer screening including fecal occult blood test, sigmoidoscopy, colonoscopy; personal history of surgery including polypectomy, other bowel surgery and hysterectomy; frequency of meat consumption and method of cooking; reproductive history (for women). Participants were also asked for detail information on the frequency of food consumption and portion size using a food frequency questionnaire. Follow-up of participants has been conducted every five years, by questionnaire, to update vital status, surgery, cancer screening, polypectomy, and personal and family history of cancer history. Participants have been characterized for major known predisposing CRC gene mutations and have undergone a genome-wide SNP testing and tested for known CRC SNPs.

Results: The Colon CFR has enrolled 35,297 participants (11,635 affected with CRC, 3,629 affected with other cancers, and 20,033 unaffected) who have completed baseline questionnaires. We have 5-year follow-up data on 24,692 participants (6,329 affected with CRC, 2,261 affected with other cancers, and 16,102 unaffected) and 10-year follow-up data on 10,467 (3,654 affected with CRC, 1,182 affected with other cancers, and 5,631 unaffected). We have GWAS data on 3,830 participants, candidate SNP data on 18,000 participants, and mismatch repair gene mutation data on 2,697 participants (and observed 1,697 carriers with a deleterious mutation).

Conclusion: This largest and best characterized CRC cohort in the world will facilitate post-GWAS research to provide insight into the role of environmental factors, and how they interact with genetic factors on CRC risk. Researchers are encouraged by the National Cancer Institute (USA) and the Colon CFR investigators to apply for access to this unique resource of data and biospecimens for collaborative research.

Citation Format: Aung Ko Win, Daniel D. Buchanan, Noralane M. Lindor, Robert W. Haile, Polly A. Newcomb, Loic Le Marchand, Steven Gallinger, Hopper L. John, Casey Graham, Mark A. Jenkins. The Colon Cancer Family Registry: A major resource for post-GWAS gene-environment studies. [abstract]. In: Proceedings of the AACR Special Conference on Post-GWAS Horizons in Molecular Epidemiology: Digging Deeper into the Environment; 2012 Nov 11-14; Hollywood, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(11 Suppl):Abstract nr 43.

  • ©2012 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 21 (11 Supplement)
November 2012
Volume 21, Issue 11 Supplement
  • Table of Contents

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 43: The Colon Cancer Family Registry: A major resource for post-GWAS gene-environment studies.
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract 43: The Colon Cancer Family Registry: A major resource for post-GWAS gene-environment studies.
Aung Ko Win, Daniel D. Buchanan, Noralane M. Lindor, Robert W. Haile, Polly A. Newcomb, Loic Le Marchand, Steven Gallinger, Hopper L. John, Casey Graham and Mark A. Jenkins
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 43; DOI: 10.1158/1055-9965.GWAS-43

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 43: The Colon Cancer Family Registry: A major resource for post-GWAS gene-environment studies.
Aung Ko Win, Daniel D. Buchanan, Noralane M. Lindor, Robert W. Haile, Polly A. Newcomb, Loic Le Marchand, Steven Gallinger, Hopper L. John, Casey Graham and Mark A. Jenkins
Cancer Epidemiol Biomarkers Prev November 1 2012 (21) (11 Supplement) 43; DOI: 10.1158/1055-9965.GWAS-43
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Proffered Abstracts - Poster Presentations

  • Abstract 79: The relationship between abdominal fat distribution, vitamin D levels, and physical activity in colorectal cancer patients: A pilot study.
  • Abstract 81: Dietary supplement use among German colorectal cancer patients: The ColoCare Study.
  • Abstract 82: Gene expression induced by acrylamide and glycidamide in mammalian cells.
Show more Proffered Abstracts - Poster Presentations

Molecular Epidemiology and Gene-Environment Interactions

  • Abstract PR2: Pathway-based gene-environment interactions in ovarian cancer.
  • Abstract PR6: Genetically determined differences in arsenic metabolism efficiency influence risk for premalignant skin lesions in Bangladesh: Mendelian randomization and gene-environment interaction.
  • Abstract PR1: LINE-1 %5-methyl cytosine levels in prediagnostic leukocyte DNA and future bladder cancer risk among PLCO and ATBC cohort subjects.
Show more Molecular Epidemiology and Gene-Environment Interactions
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement